# JKAMP

## Overview
JKAMP, or JNK1/MAPK8 associated membrane protein, is a gene that encodes a seven-transmembrane protein involved in critical cellular signaling pathways. This protein is primarily located in the plasma membrane and plays a pivotal role in modulating the activity of JNK1, a protein kinase activated in response to stress. Through its interaction with JNK1, JKAMP influences various cellular processes, including apoptosis, differentiation, and proliferation. Notably, JKAMP is integral to the Wnt signaling pathway, which is essential for osteogenic differentiation and bone development. This involvement underscores its significance in maintaining cellular homeostasis and adaptation to external stimuli. Alterations in JKAMP expression have been linked to conditions such as diabetic osteoporosis, where its downregulation correlates with impaired bone regeneration (Peng2021JKAMP).

## Function
JKAMP, or JNK1/MAPK8 associated membrane protein, is a seven-transmembrane protein primarily located in the plasma membrane of cells. It plays a significant role in cellular signaling pathways, particularly those related to stress responses and apoptosis. JKAMP is involved in modulating the activity and duration of JNK1, a protein kinase that is activated in response to stress and is known to regulate various cellular processes, including apoptosis, differentiation, and proliferation (Peng2021JKAMP).

In healthy human cells, JKAMP influences the Wnt signaling pathway, which is crucial for osteogenic differentiation and bone development. It does so by interacting with JNK1, which cooperates with β-catenin to participate in the canonical Wnt pathway. This interaction affects the expression of β-catenin and p-GSK-3β, both of which are important for osteogenesis (Peng2021JKAMP). JKAMP's role in these pathways suggests it is integral to maintaining cellular homeostasis and adaptation to external stimuli.

The protein's activity in the cell membrane and its involvement in the Wnt signaling pathway highlight its importance in regulating bone metabolism and the osteogenic ability of mesenchymal stem cells (Peng2021JKAMP).

## Clinical Significance
The JKAMP gene, also known as JNK1/MAPK8 associated membrane protein, plays a significant role in the osteogenic capacity of adipose-derived stem cells (ASCs) in the context of diabetic osteoporosis (DOP). Alterations in JKAMP expression are linked to impaired bone regeneration and healing in DOP, a condition characterized by increased bone fragility due to diabetes mellitus. In DOP-ASCs, JKAMP expression is downregulated, which correlates with decreased osteogenic potential. This downregulation is associated with increased intragenic DNA methylation, which inhibits the Wnt signaling pathway, crucial for bone metabolism and osteogenic differentiation (Peng2021JKAMP).

Silencing JKAMP in control ASCs suppresses the Wnt signaling pathway, reducing osteogenic ability, while overexpressing JKAMP in DOP-ASCs can enhance their osteogenic capacity. This suggests that JKAMP is a critical modulator of the Wnt pathway through epigenetic mechanisms, particularly intragenic methylation, rather than promoter methylation (Peng2021JKAMP). Although the study does not directly link JKAMP mutations to other diseases, its role in modulating pathways related to cellular stress responses and apoptosis suggests potential implications in conditions such as inflammation, cancer, and neurodegenerative diseases (Peng2021JKAMP).

## Interactions
JKAMP, a seven-transmembrane protein located in the plasma membrane, is involved in cellular signaling pathways, particularly in the context of diabetic osteoporosis. It interacts with JNK1, a protein kinase that plays a significant role in the Wnt-PCP signaling pathway. This interaction influences the Wnt signaling pathway, which is crucial for osteogenic differentiation and bone development. JKAMP modulates the activity of JNK1, affecting the expression levels of β-catenin and p-GSK-3β, which are key components of the Wnt signaling pathway. Silencing JKAMP leads to decreased expression of these proteins by reducing JNK1 expression, while overexpression of JKAMP increases their levels by upregulating JNK1 (Peng2021JKAMP).

The study also highlights the role of intragenic DNA methylation in regulating JKAMP expression. Increased methylation near exon 4 of JKAMP correlates with decreased mRNA levels in diabetic osteoporosis adipose-derived stem cells (DOP-ASCs), suggesting that intragenic methylation, rather than promoter methylation, is responsible for the reduced expression of JKAMP in these cells (Peng2021JKAMP). However, specific physical interactions of JKAMP with other proteins or nucleic acids are not detailed in the available excerpts (Peng2021JKAMP).


## References


[1. (Peng2021JKAMP) Shuanglin Peng, Sirong Shi, Gang Tao, Yanjing Li, Dexuan Xiao, Lang Wang, Qing He, Xiaoxiao Cai, and Jingang Xiao. Jkamp inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the wnt signaling pathway through intragenic dna methylation. Stem Cell Research &amp; Therapy, February 2021. URL: http://dx.doi.org/10.1186/s13287-021-02163-6, doi:10.1186/s13287-021-02163-6. This article has 20 citations.](https://doi.org/10.1186/s13287-021-02163-6)